期刊文献+

GP73在肝细胞癌诊断中的价值 被引量:12

The diagnostic value of serum Golgi protein-73 in hepatocellular carcinoma
原文传递
导出
摘要 目的:探讨GP73(Golgi protein-73)在肝细胞癌诊断中的价值。方法:收集外周血血清504例,其中肝细胞癌144例、肝硬化50例、乙型病毒性肝炎100例、乙型肝炎病毒携带者84例、其他恶性肿瘤50例、肝良性肿瘤26例和健康志愿者50例;应用双抗体夹心酶联免疫定量测定方法和电化学发光法检测血清中GP73和甲胎蛋白(α-fetoprotein,AFP)的表达水平。结果:肝细胞癌组血清GP73的表达水平显著高于其他各组(P<0.05);受试者工作特征(receiver operating characteristic,ROC)曲线设定GP73临界值为64ng/mL时,GP73诊断肝细胞癌的灵敏度和特异度分别为83.3%和88.3%,显著高于AFP(72.2%和76.7%),差异有统计学意义(P<0.05);血清GP73联合AFP检测诊断肝细胞癌的灵敏度可达94.4%。结论:血清GP73的表达水平用于诊断肝细胞癌的灵敏度和特异度优于AFP,血清GP73联合AFP检测可提高肝细胞癌的诊断率。 Objective:To investigate the diagnostic value of serum Golgi protein-73(GP73) in hepatocellular carcinoma(HCC).Methods:The peripheral serum samples from 504 individuals were collected,including 144 HCC patients,50 cirrhotic patients,100 hepatitis B patients,84 hepatitis B virus carriers,50 patients with other malignancies,26 patients with benign liver tumor,and 50 healthy volunteers.The expression levels of serum GP73 and alpha-fetal protein(AFP) were detected by double antibody sandwich ELISA and electrochemiluminescence assay,respectvely.Results:The expression level of serum GP73 from the HCC patients was significantly higher than those from the other patient groups(P0.05).When the cut-off value was determined as 64 ng/mL by the receiver operating characteristic(ROC) curve,the sensitivity and specificity of GP73 for the diagnosis of HCC were both higher than those of AFP(83.3% vs 72.2%;88.3% vs 76.7%;both P0.05).The sensitivity of GP73 in combination with serum AFP for the diagnosis of HCC was 94.4%.Conclusion:The sensitivity and specificity of serum GP73 for the diagnosis of HCC are higher than those of serum AFP.The rate of HCC diagnosis is increased by combined examination of serum GP73 and AFP.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第2期115-118,共4页 Tumor
基金 广西科学基金资助项目(编号:桂科自0832235) 广西科学研究与技术开发计划资助项目(编号:桂科攻0816004-13) 广西科学研究与技术开发计划资助项目(编号:桂科攻1140003A-32) 2011年广西研究生教育创新计划资助项目(编号:2011105981002D28)
关键词 肝细胞 血清 诊断 GOLGI protein-73 甲胎蛋白 Carcinoma hepatocellular Serum Diagnosis Golgi protein-73 α-fetoprotein
  • 相关文献

参考文献4

二级参考文献21

  • 1袁联文,唐伟,李永国,幕内雅敏.脱-γ-羧基凝血酶原:一种有用的血清肝癌标志物[J].中华普通外科杂志,2004,19(8):506-506. 被引量:11
  • 2Chaur-Shine Wang,Chin-Lin Lin,Hsi-Chang Lee,Kuan-Yang Chen,Ming-Feng Chiang,Hung-Sheng Chen,Tsung-Jung Lin.Usefulness of serum des-γ-carboxy prothrombin in detection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(39):6115-6119. 被引量:20
  • 3Amal Gad,Eiji Tanaka,Akihiro Matsumoto,Moushira Abd-el Wahab,Abd el-Hamid Serwah,Fawzy Attia,Khalil Ali,Howayda Hassouba,Abd el-Raoof el-Deeb,Tetsuya Ichijyo,Takeji Umemura,Hidetomo Muto,Kaname Yoshizawa,Kendo Kiyosawa.Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(42):6607-6612. 被引量:8
  • 4Cassandra Willyard. Researchers look for ‘sweet' method to diagnose cancer. Nat Med, 2007, 13: 1267.
  • 5Kladney RD, Bulla GA, Guo L, et al. GP73, a novel golgilocalized protein upregulated by viral infection. Gene, 2000, 249 : 53-65.
  • 6Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology, 2002, 35 : 1431-1440.
  • 7Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol, 2005, 43: 1007-1012.
  • 8Kladney RD,Bulla GA,Guo L,et al.GP73,a novel Golgi-localized protein upregulated by viral infection.Gene,2000,249:53-65.
  • 9Block TM,Comunale MA,Lowman M,et al.Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.Proc Natl Acad Sci U S A,2005,102:779-784.
  • 10Schwegler EE,Cazares L,Steel LF,et al.SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.Hepatology,2005,41:634-642.

共引文献212

同被引文献139

  • 1原发性肝癌的临床诊断与分期标准[J].肝脏,2004,9(S1):67-68. 被引量:53
  • 2杨盛力,潘晓莉.GP73的研究进展[J].肝胆外科杂志,2011,19(1):70-72. 被引量:15
  • 3Lin Zhou,Jia Liu,Feng Luo.Serum tumor markers for detection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(8):1175-1181. 被引量:79
  • 4陆守曾.陈峰.医学统计学[M].2版.北京:中国统计出版社.2007:69-70.
  • 5Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis,2010,30( 1 ) :3 - 16.
  • 6Feher J, Lengyel G. Hepatocellular carcinoma : occurrence, risk fac- tors, biomarkers. Orv Hetil,2010,151 (23) :933 - 940.
  • 7Bruix J, Sherman M. Management of hepatocellular carcinoma. Hep- atology ,2005,42 ( 5 ) : 1208 - 1236.
  • 8Wang M, Long RE, Comunale MA, et al. Novel fucosylated biomar- kers for the early detection of hepatocellular carcinoma. Cancer Epi- demiol Biomarkers Prev, 2009, 18 (6) :1914 -1921.
  • 9Mao Y, Yang H, Xu 17, et al. Golgi protein 73 (GOLPH2) is a val- uable serum marker for hepatocellular carcinoma. Gut, 2010, 59 (12) :1687 - 1693.
  • 10Shi Y, Chert J, Li L, A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma. Technol Cancer Res Treat, 2011,10 ( 3 ) : 287 - 294.

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部